Agilent Technologies (A) Stock Forecast, Price & News

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 3 hold ratings and 11 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" A shares.
View A analyst ratings or view top-rated stocks.

14 brokers have issued 12-month target prices for Agilent Technologies' stock. Their A share price forecasts range from $126.00 to $170.00. On average, they expect the company's share price to reach $151.35 in the next twelve months. This suggests a possible upside of 28.9% from the stock's current price.
View analysts price targets for A or view top-rated stocks among Wall Street analysts.

Agilent Technologies' stock was trading at $149.65 at the beginning of the year. Since then, A stock has decreased by 21.5% and is now trading at $117.44.
View the best growth stocks for 2023 here.

Agilent Technologies saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 5,220,000 shares, an increase of 7.9% from the April 30th total of 4,840,000 shares. Based on an average daily volume of 1,600,000 shares, the days-to-cover ratio is currently 3.3 days. Currently, 1.8% of the shares of the stock are short sold.
View Agilent Technologies' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 15th 2023.
View our A earnings forecast.

Agilent Technologies, Inc. (NYSE:A) issued its quarterly earnings data on Tuesday, May, 23rd. The medical research company reported $1.27 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.01. The medical research company earned $1.72 billion during the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a trailing twelve-month return on equity of 30.11% and a net margin of 19.19%. The company's revenue for the quarter was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.13 EPS.
Read the conference call transcript.

Agilent Technologies declared a quarterly dividend on Wednesday, May 17th. Investors of record on Monday, July 3rd will be given a dividend of $0.225 per share on Wednesday, July 26th. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date is Friday, June 30th.
Read our dividend analysis for A.

ETFs with the largest weight of Agilent Technologies (NYSE:A) stock in their portfolio include Global X Genomics & Biotechnology ETF (GNOM), Global X Telemedicine & Digital Health ETF (EDOC), Subversive Metaverse ETF (PUNK), First Trust Water ETF (FIW), ProShares Nanotechnology ETF (TINY), BTD Capital Fund (DIP), Hennessy Stance ESG Large Cap ETF (STNC) and Kelly CRISPR & Gene Editing Technology ETF (XDNA).

Agilent Technologies (NYSE:A) pays an annual dividend of $0.90 per share and currently has a dividend yield of 0.76%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 19.82%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 14.83% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

Agilent Technologies declared that its Board of Directors has initiated a stock buyback plan on Monday, January 9th 2023, which permits the company to repurchase $2,000,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization permits the company to buy up to 4.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company's board of directors believes its stock is undervalued.

Agilent Technologies updated its third quarter 2023 earnings guidance on Friday, May, 26th. The company provided EPS guidance of $1.36-$1.38 for the period, compared to the consensus EPS estimate of $1.43. The company issued revenue guidance of $1.64 billion-$1.68 billion, compared to the consensus revenue estimate of $1.77 billion.

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Agilent Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (10.65%), State Street Corp (4.38%), Wellington Management Group LLP (4.08%), Price T Rowe Associates Inc. MD (2.78%), Geode Capital Management LLC (2.10%) and Pictet Asset Management SA (1.79%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends.

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of A stock can currently be purchased for approximately $117.44.

Agilent Technologies (NYSE:A) has a market capitalization of $34.69 billion and generates $6.85 billion in revenue each year. The medical research company earns $1.25 billion in net income (profit) each year or $4.54 on an earnings per share basis.

The company employs 18,100 workers across the globe.

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.